Enhancing lead immobilization by biochar: Creation of "surface barrier" via bio-treatment.

The long-term effectiveness of heavy metal immobilization is always a concern. This study proposes a completely novel approach to enhance the stability of heavy metals by combined biochar and microbial induced carbonate precipitation (MICP) technology, to create a "surface barrier" of CaCO3 layer on biochar after lead (Pb2+) immobilization. Aqueous sorption studies and chemical and micro-structure tests were used to verify the feasibility. Rice straw biochar (RSB700) was produced at 700 °C, which shows high immobilization capacity of Pb2+ (maximum of 118 mg g-1). But the stable fraction only accounts for 4.8% of the total immobilized Pb2+ on biochar. After MICP treatment, the stable fraction of Pb2+ significantly increased to a maximum of 92.5%. Microstructural tests confirm the formation of CaCO3 layer on biochar. The CaCO3 species are predominantly calcite and vaterite. Higher Ca2+ and urea concentrations in cementation solution resulted in higher CaCO3 yield but lower Ca2+ utilization efficiency. The main mechanism of the "surface barrier" to enhance Pb2+ stability on biochar was likely the encapsulation effect: it physically blocked the contact between acids and Pb2+ on biochar, and chemically buffer the acidic attack from the environment. The performance of the "surface barrier" depends on both the yield of CaCO3 and their distribution uniformity on biochar's surface. This study shed lights on the potential application of the "surface barrier" strategy combining biochar and MICP technologies for enhanced heavy metal immobilization.

The role of bone morphogenetic protein 4 in corneal injury repair.

PURPOSE: Corneal injury may cause neovascularization and lymphangiogenesis in cornea which have a detrimental effect to vision and even lead to blindness. Bone morphogenetic protein 4 (BMP4) regulates a variety of biological processes, which is closely relevant to the regulation of corneal epithelium and angiogenesis. Herein, we aimed to evaluate the effect of BMP4 on corneal neovascularization (CNV), corneal lymphangiogenesis (CL), corneal epithelial repair, and the role of BMP4/Smad pathway in these processes. METHODS: We used MTT assay to determine the optimal concentration of BMP4. The suture method was performed to induce rat CNV and CL. We used ink perfusion and HE staining to visualize the morphological change of CNV, and utilized RT-qPCR and ELISA to investigate the expression of angiogenic factors and lymphangiogenic factors. The effects of BMP4 and anti-VEGF antibody on migration, proliferation and adhesion of corneal epithelium were determined by scratch test, MTT assay and cell adhesion test. RESULTS: BMP4 significantly inhibited CNV and possibly CL. Topical BMP4 resulted in increased expression of endogenous BMP4, and decreased expression of angiogenic factors and lymphangiogenic factors. Compared with anti-VEGF antibody, BMP4 enhanced corneal epithelium migration, proliferation and adhesion, which facilitated corneal epithelial injury repair. Simultaneously, these processes could be regulated by BMP4/Smad pathway. CONCLUSIONS: Our results demonstrated unreported effects of BMP4 on CNV, CL, and corneal epithelial repair, suggesting that BMP4 may represent a potential therapeutic target in corneal injury repair.

Electrochemically Driven Phase Transition in LiCoO2 Cathode.

Lithium cobalt oxide (LiCoO2), which has been successfully applied in commercial lithium-ion batteries for portable devices, possesses a theoretical specific capacity of 274 mAh g-1. However, its actual capacity is only half of the theoretical specific capacity, because the charging voltage is restricted below 4.2 V. If a higher charging voltage is applied, an irreversible phase transition of LiCoO2 during delithiation would occur, resulting in severe capacity fading. Therefore, it is essential to investigate the electrochemically driven phase transition of LiCoO2 cathode material to approach its theoretical capacity. In this work, it was observed that LiCoO2 partially degraded to Co3O4 after 150 charging-discharging cycles. From the perspective of crystallography, the conventional cell of LiCoO2 was rebuilt to an orthonormal coordinate, and the transition path from layered LiCoO2 to cubic Co3O4 proposed. The theoretical analysis indicated that the electrochemically driven phase transition from LiCoO2 to Co3O4 underwent several stages. Based on this, an experimental verification was made by doping LiCoO2 with Al, In, Mg, and Zr, respectively. The doped samples theoretically predicted behavior. The findings in this study provide insights into the electrochemically driven phase transition in LiCoO2, and the phase transition can be eliminated to improve the capacity of LiCoO2 to its theoretical value.

Thermoresponsive gel for sustained release of BMP4 to inhibit corneal neovascularization.

This work aimed to seek a sustained drug release system based on poloxamer-based thermoresponsive gel for sustained release drugs to inhibit corneal neovascularization (CNV) after eye operations. Thus, we designed and prepared a thermoresponsive gel with a phase transition temperature from 22 °C to 25 °C. When the concentrations of poloxamer (P) was 18% (w/w) and ε-Polylysine (EPL) was 0.5 mg/mL (P-18-EPL-05) in the thermoresponsive gel solution, the obtained thermoresponsive gel showed a suitable viscosity and strength in physiological condition. The viscosity, storage modulus G' and loss modulus G" of P-18-EPL-05 were 8 × 102 mPa.s, 1.17 × 104 Pa and 3.77 × 103 Pa, respectively. In-vitro release studies indicated that the drug release ratio of P-18-EPL-05 gel better than that of the poloxamer solution alone. The animal experiments indicated that the thermoresponsive gel loading bone morphogenetic protein 4 (BMP4) was better to inhibit CNV than the common solvent one. Overall, these results demonstrated that P-18-EPL-05 gel would be a promising platform as drug sustained systems for inhibiting CNV after eye injury in ophthalmic applications.

Regulation of bone morphogenetic protein 4 on epithelial tissue.

Epithelial tissues provide tissue barriers and specialize in organs and glands. When epithelial homeostasis is physiologically or pathologically stimulated, epithelial cells produce mesenchymal cells through the epithelial-mesenchymal transition, forming new tissues, promoting the cure of diseases or leading to illness. A variety of cytokines are involved in the regulation of epithelial cell differentiation. Bone morphogenetic proteins (BMPs), especially the bone morphogenetic protein 4 (BMP4) has a variety of biological functions and plays a prominent role in the regulation of epithelial cell differentiation. BMP4 is an important regulatory factor of a series of life activities in vertebrates, which is also related to cell proliferation, differentiation and mobility, it also has relation with tumor development. This paper mainly reviews the mechanism of BMP4's regulation on epithelial tissues, as well as its effect on the growth, differentiation, benign lesions and malignant lesions of epithelial tissues, and expounds the function of BMP4 in epithelial tissues, to provide theoretical support for the research on reducing epithelial diseases.

Expression and purification of Huwentoxin-I in baculovirus system.

Huwentoxin-I (HWTX-I) is a novel neurotoxin isolated from the venom of Orinithoctonus huwena. Based on its biological activity, HWTX-I could be developed as a pain-killer for clinical purpose. Production of HWTX-I by the bacterium or yeast expression systems resulted in poor yields and the purified protein was proved to have lower biological activity than that of native one. So, for the first time, we introduced a new method to express HWTX-I gene in Sf9 cells using baculovirus expression system. Recombinant HWTX-I was recognized by Western blotting and then purified by nickel-chelating affinity chromatography under native conditions. Recombinant HWTX-I showed identical amino acid sequence as native form and exhibited similar effect on muscular transmission with that of native form. These results indicate that the baculovirus expression system and native purification strategy are viable ways to produce active HWTX-I.